NFA
ANIP icon

Nationwide Fund Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Nationwide Fund Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,287
Closed -$278K – 124
2017
Q3 		$278K Sell
5,287
-11,382
-68% -$543K ﹤0.01% 2474
2017
Q2 		$780K Buy
16,669
+12,136
+268% +$585K ﹤0.01% 1929
2017
Q1 		$224K Sell
4,533
-341
-7% -$19.1K ﹤0.01% 2535
2016
Q4 		$295K Sell
4,874
-227
-4% -$13.9K ﹤0.01% 2432
2016
Q3 		$338K Hold
5,101
– – ﹤0.01% 2367
2016
Q2 		$285K Sell
5,101
-169
-3% -$8.21K ﹤0.01% 2437
2016
Q1 		$177K Hold
5,270
– – ﹤0.01% 2585
2015
Q4 		$238K Buy
5,270
+161
+3% +$6.93K ﹤0.01% 2460
2015
Q3 		$202K Hold
5,109
– – ﹤0.01% 2562
2015
Q2 		$317K Buy
5,109
+76
+2% +$4.52K ﹤0.01% 2484
2015
Q1 		$315K Sell
5,033
-128
-2% -$7.79K ﹤0.01% 2471
2014
Q4 		$291K Sell
5,161
-96
-2% -$4.23K ﹤0.01% 2471
2014
Q3 		$149K Sell
5,257
-4
-0.1% -$120 ﹤0.01% 2834
2014
Q2 		$181K Buy
+5,261
New +$165K ﹤0.01% 2800

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nationwide Fund Advisors's ANIP Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of ANI Pharmaceuticals (ANIP) in Q4 2017, closing a stake of 5,287 shares — an estimated $278K sold.

Nationwide Fund Advisors first reported a position in ANIP in Q2 2014 and held it in 14 quarters. The position peaked at $780K in Q2 2017. 163 funds tracked by Wall St. Rank hold ANIP as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining ANI Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 5,287 ANI Pharmaceuticals shares in Q4 2017, an estimated $278K.
  • Nationwide Fund Advisors first reported a position in ANI Pharmaceuticals in Q2 2014 and held it in 14 quarters.
  • Nationwide Fund Advisors's ANI Pharmaceuticals position peaked at $780K in Q2 2017.
  • 163 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.